Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of protein-protected mRNA fragments and structured excised intron RNAs in human plasma by TGIRT-seq peak calling. | Elife | 2020 | 32876046 | PubTator, text mining | PubMed |
| LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA. | Cancer Med | 2020 | 32871048 | PubTator, text mining | PubMed |
| The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer. | Cell Oncol (Dordr) | 2020 | 32857323 | PubTator, text mining | PubMed |
| Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review. | World J Clin Oncol | 2020 | 32855905 | PubTator, text mining | PubMed |
| Integrated analysis of RNA-binding proteins in human colorectal cancer. | World J Surg Oncol | 2020 | 32828126 | PubTator, text mining | PubMed |
| Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. | Cancers (Basel) | 2020 | 32825087 | PubTator, text mining | PubMed |
| IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells. | Int J Mol Sci | 2020 | 32823550 | PubTator, text mining | PubMed |
| Temporal patterning in neural progenitors: from Drosophila development to childhood cancers. | Dis Model Mech | 2020 | 32816915 | PubTator, text mining | PubMed |
| TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs. | Cell Cycle | 2020 | 32816599 | PubTator, text mining | PubMed |
| NLRP7 plays a functional role in regulating BMP4 signaling during differentiation of patient-derived trophoblasts. | Cell Death Dis | 2020 | 32814763 | PubTator, text mining | PubMed |
| Ribosomal proteins: mutant phenotypes by the numbers and associated gene expression changes. | Open Biol | 2020 | 32810425 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer. | J Exp Clin Cancer Res | 2020 | 32807223 | PubTator, text mining | PubMed |
| Chronic ethanol consumption and HBV induce abnormal lipid metabolism through HBx/SWELL1/arachidonic acid signaling and activate Tregs in HBV-Tg mice. | Theranostics | 2020 | 32802190 | PubTator, text mining | PubMed |
| "Reprogram Enablement" as an Assay for Identifying Early Oncogenic Pathways by Their Ability to Allow Neoplastic Cells to Reacquire an Epiblast State. | Stem Cell Reports | 2020 | 32795421 | PubTator, text mining | PubMed |
| Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors. | Cells | 2020 | 32784606 | PubTator, text mining | PubMed |
| Nucleosome allostery in pioneer transcription factor binding. | Proc Natl Acad Sci U S A | 2020 | 32778600 | PubTator, text mining | PubMed |
| Novel insights into the interplay between m6A modification and noncoding RNAs in cancer. | Mol Cancer | 2020 | 32767982 | PubTator, text mining | PubMed |
| The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer. | Nucleic Acids Res | 2020 | 32761127 | PubTator, text mining | PubMed |
| Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication. | Biomedicines | 2020 | 32756339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=53